Cardiovascular Disease
Social determinants linked to ‘dramatic differences’ in heart health for cancer survivors
Among adult cancer survivors in the United States, a suboptimal social determinants of health profile had an independent association with worse cardiovascular health, according to a study published in JACC: CardioOncology.
Tackling the Disproportionate Burden of Resistant Hypertension in Black Adults
This activity is supported by an educational grant from Medtronic
Use ‘more precise’ CVD risk scores to target therapy intensity for people with diabetes
Composite CVD risk factor control for U.S. adults with type 2 diabetes remains poor, but clinicians can use newer risk scores to better assess patients and prevent CV events with targeted therapies, according to a speaker.
Antiphospholipid antibodies increase risk for future cardiovascular disease in lupus
SAN DIEGO — Patients with systemic lupus erythematosus who are positive for antiphospholipid antibodies have a greater risk for future atherosclerotic cardiovascular disease, according to data presented at ACR Convergence 2023.
Addressing and Treating Iron Deficiency to Improve Symptoms and Outcomes in Patients with Heart Failure
This activity is supported by an educational grant from American Regent.
Women with prediabetes may benefit from earlier intervention to prevent CVD
Compared with men, women with prediabetes may benefit from earlier intervention to prevent cardiovascular disease, according to a presenter at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease Conference.
Cancer drug class associated with high risk for cardiovascular adverse events
SAN DIEGO — Individuals treated with first-generation Bruton tyrosine kinase inhibitors with preexisting cardiovascular disease had significantly higher odds of developing cardiovascular adverse events, study results showed.
Updated recommendations, panel sessions among highlights at 21st annual WCIRDC meeting
Presentations on the latest cardiometabolic research, panel discussions and updated practice recommendations are among this year’s highlights at the 21st World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.
Long-term hormone therapy after hysterectomy yields benefits up to 20 years
Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.
Smoking cessation significantly reduces excess mortality within a decade
A recent study showed that excess cardiovascular and respiratory mortality among former smokers was less than half of that among continuing smokers within the first decade of smoking cessation.